Skip to main content
. Author manuscript; available in PMC: 2015 Jan 28.
Published in final edited form as: Br J Haematol. 2011 Aug 25;155(2):150–166. doi: 10.1111/j.1365-2141.2011.08852.x

Table 2.

Summary of gene expression analysis of MF/SS from microarray studies.

Authors Platform Source Findings
Willers et al (2001) 588 gene Atlas membrane array SS cells/skin derived T cell culture Interferon inhibiting cytokine factor
Kari et al (2003) cDNA filter – 4500 genes SS PBMC PLS3, GATA3, JUNB, ITGB1, PRG2, RHOB (ARHB), decreased DPP4, STAT4 and IL1R1
Tracey et al (2003) cDNA oncochip - 6386 MF skin 27 genes – BIRC3, BIRC1, TRAF, TNFR apoptosis regulators, STAT4, CD40L
Mao et al (2004) Affy cDNA HuGenFl (12k) MF/SS JUNB and BCL2 increased copy number. Affy showed decreased RASA1, STAT3, STAT4, STAT5A
Van Doorn (2004) Affy U95A SS Increased: EPHA4 and TWIST1. Decreased: TGFBR2, MXI1, PRDM2, STAT4, BCL11A
Mao et al (2006) FISH, Affy U133A (13.5k genes) MF/SS CCND1/BCL1 increased in some. EB1 loss, CCND2, CCND3 increased
Mao et al (2008) FISH, Affy U133A SS JUNB and JUND increased. Phosphorylated MAPK1 (ERK). Increase JUNB copy number
Hahtola (2006) Affy U133A Skin and blood, CD4 Th2 cytokine increased in SS, loss of T-bet (TBX21) NKG7 and CCL5 (SCYA5) decreased in SS
Booken et al (2008) AffyU133 Plus2(54k genes) CD4 7 genes significant – CDO1, DNM3, NEDD4L, IGFL2, TNFSF11, KLHDC5. TWIST1 affects DNM3 and CDO1
Kennah et al (2009) Affy 133Plus2 Hut78 HCK, AHI1, BIN1 in transformed MF
Wozniak (et al 2009) cDNA oncochip 6386 MF skin, PUVA-resistant NF-kB TCR signalling altered in PUVA resistance. Increased NFKB1, and Th2 signalling. Differences seen in tumour microenvironment
Shin et al (2007) AffyU133A MF skin 3 clusters- T cell genes in cluster 1, LOR in cluster 2, FOSL1, SERPINB13 in cluster 3.
Litvinov et al (2010) AffyU133A MF skin WIF1 favourable prognosis, IL17F poor prognosis
Chong et al (2010) AffyU133 Plus2 PBMC, SS 9/14 memory genes decreased in SS
Pomerantz et al (2010) Illumina Sentrix 24k genes CD4/CD45RO cells ZBTB16 increased, IRF3 and IFI35 decreased

SS, Sezary Syndrome; MF, Mycosis Fungoides; PBMC, peripheral blood mononuclear cells; PUVA, psoralen combined with ultraviolet A.